O'Neill Vincent 4
4 · BioXcel Therapeutics, Inc. · Filed Dec 18, 2023
Insider Transaction Report
Form 4
O'Neill Vincent
Other
Transactions
- Exercise/Conversion
Common Stock
2023-12-14+521→ 2,802 total - Exercise/Conversion
Restricted Stock Units
2023-12-14−521→ 4,690 total→ Common Stock (521 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.